Ronald Muhlenkamp - Muhlenkamp & Co 13F Activity & Position Changes (Q2 2018)

As of Jun 30, 2018, the Muhlenkamp & Co portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 06, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2018, the filing reported:

New Buys - Invesco BuyBack Achievers ETF

Increases - Pfizer, Inc.

Reductions - Bread Financial Holdings, Inc., Delta Air Lines, Inc., Gilead Sciences, Inc., ON Semiconductor Corporation

Complete Exits - Bristol-Myers Squibb Company

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q2 2018	BFH Bread Financial Holdings, Inc.	Bread Financial Holdings, Inc.	Sell	-10	-0.0%	$16.45K	70,519
Q2 2018	BMY Bristol-Myers Squibb Company	Bristol-Myers Squibb Company	Sell - Position Exit	-178,436	-100.0%	$0.00	-
Q2 2018	DAL Delta Air Lines, Inc.	Delta Air Lines, Inc.	Sell	-55	-0.0%	$5.71K	115,308
Q2 2018	GILD Gilead Sciences, Inc.	Gilead Sciences, Inc.	Sell	-86,153	-38.7%	$9.65K	136,224
Q2 2018	ON ON Semiconductor Corporation	ON Semiconductor Corporation	Sell	-172,948	-24.4%	$11.93K	536,518
Q2 2018	PFE Pfizer, Inc.	Pfizer, Inc.	Buy	+246	+0.9%	$997.00	27,485
Q2 2018	PKW Invesco BuyBack Achievers ETF	Invesco BuyBack Achievers ETF	Buy - Position Entry	+36,381	-	$2.06K	36,381